Wontech, a leading medical solutions company specializing in laser and energy-based technologies, has announced plans to repurchase 6 billion KRW (approximately 4 million USD) worth of its own shares. The company will execute this buyback through a trust agreement with Samsung Securities.
The move, disclosed on Monday, is aimed at boosting shareholder value and reinforcing market confidence in the company’s prospects.
This latest initiative follows Wontech’s April 8 announcement of the cancellation of 437,749 treasury shares. The company emphasized that this stock repurchase program is part of a broader strategy to provide tangible returns to shareholders, rather than simply holding onto the acquired shares.
Looking ahead to 2025, Wontech projects impressive financial results on a consolidated basis. The company anticipates sales of 156.8 billion KRW (about 105.4 million USD) and an operating profit of 51.7 billion KRW (about 34.7 million USD), reflecting both top-line growth and enhanced profitability. Notably, the company expects to achieve an operating profit margin of 33%. Furthermore, Wontech’s export ratio is set to climb to 70%, underscoring its increasingly global-centric growth trajectory.
Building on its strong performance and competitive edge in the market, Wontech is committed to further strengthening its shareholder-friendly policies in the coming years.
A spokesperson for Wontech stated that this share repurchase program is more than just a financial maneuver; it’s a strategic investment in the company’s future. It intends to leverage these shares to enhance the corporate value actively. As it continues to expand the global footprint and deliver consistent profits, it believes this decision will signal the confidence in Wontech’s growth potential to both the market and the shareholders. Moving forward, it remains dedicated to implementing measures that simultaneously boost the corporate value and provide meaningful returns to the investors.